Diagnosis and management of insulinoma

Charles Filipi, George A. Higgins

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Surgery for insulinoma represents one of the best examples of the application of the principles of physiology and pathology in therapeutics. Seven new cases of insulinoma are presented. New diagnostic tests including radioimmunoassay double antibody insulin levels and a diagnostic trial of diazoxide, an anti-insulin agent, were used. Six lesions were benign; four were treated by enucleation and two by distal pancreatectomy. The remaining patient had palliative cholecystojejunostomy for malignant insulinoma followed by chemotherapy with streptozotocin. Selective celiac angiography can now demonstrate the majority of insulinomas. With refinements in technic more nonpalpable lesions will be demonstrated, thus simplifiying the operative approach. Since 1958, 527 cases have been reported in the literature. Tabulation of nonpalpable lesions reveals that 53 per cent were located in the head of the pancreas, the remainder in the body and tail. These figures suggest that if no lesion can be located by arteriography or palpation, blind distal pancreatectomy should be performed. At this point, if no hyperglycemic response is obtained and serial frozen sections give negative results, subtotal pancreatectomy (95 per cent) will remove 90 per cent of these occult tumors.

Original languageEnglish
Pages (from-to)231-239
Number of pages9
JournalAmerican Journal of Surgery
Volume125
Issue number2
DOIs
StatePublished - 1973
Externally publishedYes

Fingerprint

Insulinoma
Pancreatectomy
Angiography
Insulin Antibodies
Diazoxide
Palpation
Frozen Sections
Streptozocin
Routine Diagnostic Tests
Abdomen
Radioimmunoassay
Pancreas
Insulin
Pathology
Drug Therapy
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Diagnosis and management of insulinoma. / Filipi, Charles; Higgins, George A.

In: American Journal of Surgery, Vol. 125, No. 2, 1973, p. 231-239.

Research output: Contribution to journalArticle

Filipi, Charles ; Higgins, George A. / Diagnosis and management of insulinoma. In: American Journal of Surgery. 1973 ; Vol. 125, No. 2. pp. 231-239.
@article{3070a4457053494dbca69ac4f9813877,
title = "Diagnosis and management of insulinoma",
abstract = "Surgery for insulinoma represents one of the best examples of the application of the principles of physiology and pathology in therapeutics. Seven new cases of insulinoma are presented. New diagnostic tests including radioimmunoassay double antibody insulin levels and a diagnostic trial of diazoxide, an anti-insulin agent, were used. Six lesions were benign; four were treated by enucleation and two by distal pancreatectomy. The remaining patient had palliative cholecystojejunostomy for malignant insulinoma followed by chemotherapy with streptozotocin. Selective celiac angiography can now demonstrate the majority of insulinomas. With refinements in technic more nonpalpable lesions will be demonstrated, thus simplifiying the operative approach. Since 1958, 527 cases have been reported in the literature. Tabulation of nonpalpable lesions reveals that 53 per cent were located in the head of the pancreas, the remainder in the body and tail. These figures suggest that if no lesion can be located by arteriography or palpation, blind distal pancreatectomy should be performed. At this point, if no hyperglycemic response is obtained and serial frozen sections give negative results, subtotal pancreatectomy (95 per cent) will remove 90 per cent of these occult tumors.",
author = "Charles Filipi and Higgins, {George A.}",
year = "1973",
doi = "10.1016/0002-9610(73)90033-0",
language = "English",
volume = "125",
pages = "231--239",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Diagnosis and management of insulinoma

AU - Filipi, Charles

AU - Higgins, George A.

PY - 1973

Y1 - 1973

N2 - Surgery for insulinoma represents one of the best examples of the application of the principles of physiology and pathology in therapeutics. Seven new cases of insulinoma are presented. New diagnostic tests including radioimmunoassay double antibody insulin levels and a diagnostic trial of diazoxide, an anti-insulin agent, were used. Six lesions were benign; four were treated by enucleation and two by distal pancreatectomy. The remaining patient had palliative cholecystojejunostomy for malignant insulinoma followed by chemotherapy with streptozotocin. Selective celiac angiography can now demonstrate the majority of insulinomas. With refinements in technic more nonpalpable lesions will be demonstrated, thus simplifiying the operative approach. Since 1958, 527 cases have been reported in the literature. Tabulation of nonpalpable lesions reveals that 53 per cent were located in the head of the pancreas, the remainder in the body and tail. These figures suggest that if no lesion can be located by arteriography or palpation, blind distal pancreatectomy should be performed. At this point, if no hyperglycemic response is obtained and serial frozen sections give negative results, subtotal pancreatectomy (95 per cent) will remove 90 per cent of these occult tumors.

AB - Surgery for insulinoma represents one of the best examples of the application of the principles of physiology and pathology in therapeutics. Seven new cases of insulinoma are presented. New diagnostic tests including radioimmunoassay double antibody insulin levels and a diagnostic trial of diazoxide, an anti-insulin agent, were used. Six lesions were benign; four were treated by enucleation and two by distal pancreatectomy. The remaining patient had palliative cholecystojejunostomy for malignant insulinoma followed by chemotherapy with streptozotocin. Selective celiac angiography can now demonstrate the majority of insulinomas. With refinements in technic more nonpalpable lesions will be demonstrated, thus simplifiying the operative approach. Since 1958, 527 cases have been reported in the literature. Tabulation of nonpalpable lesions reveals that 53 per cent were located in the head of the pancreas, the remainder in the body and tail. These figures suggest that if no lesion can be located by arteriography or palpation, blind distal pancreatectomy should be performed. At this point, if no hyperglycemic response is obtained and serial frozen sections give negative results, subtotal pancreatectomy (95 per cent) will remove 90 per cent of these occult tumors.

UR - http://www.scopus.com/inward/record.url?scp=0015578717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015578717&partnerID=8YFLogxK

U2 - 10.1016/0002-9610(73)90033-0

DO - 10.1016/0002-9610(73)90033-0

M3 - Article

VL - 125

SP - 231

EP - 239

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 2

ER -